Advanced Y3H based Protein Interaction Identification Service

Principle Platform Workflow Feature Application Advantage Related Services FAQ Online Inquiry

Creative Biolabs, with over two decades of industry-leading expertise, offers a sophisticated Yeast Three-Hybrid (Y3H) based Protein Interaction Identification Service designed to explore these complex interactions with unparalleled precision and depth. Our state-of-the-art Y3H platform is a powerful extension of the classical yeast two-hybrid (Y2H) system. It is ingeniously engineered to identify molecules that mediate or stabilize the interaction between two other molecules, acting as a crucial "bridge." This makes the Y3H system an indispensable tool for investigating RNA-protein interactions, identifying protein targets of small molecules, and dissecting the components of multi-protein complexes. By harnessing the latest advancements in Y3H technology, we provide our clients with actionable insights that accelerate research in drug discovery, functional genomics, and systems biology.

Discuss Your Project Today

The Principle of the Yeast Three-Hybrid (Y3H) System

The Y3H system is a powerful in vivo method for detecting interactions between two proteins that are mediated by a third molecule, or identifying a protein that binds to a specific RNA or small molecule bait. The principle relies on the reconstitution of a functional transcription factor (commonly GAL4) within the yeast nucleus. This transcription factor is split into two distinct domains: a DNA-Binding Domain (DBD) and a Transcriptional Activation Domain (AD).

Protein-RNA Interaction Screening

To identify proteins that bind to a specific RNA sequence (RNA-X), the system is engineered as follows:

Hybrid Protein 1: The first protein is fused to the DBD. This protein has a known affinity for one part of a hybrid RNA molecule.
Hybrid RNA: A bifunctional RNA molecule is expressed. It contains the known RNA-binding sequence recognized by the first hybrid protein, covalently linked to your target RNA sequence, RNA-X.
Hybrid Protein 2 (Prey): A cDNA library of potential RNA-binding proteins is fused to the AD.

When a prey protein from the library binds to RNA-X, it brings the AD into close proximity with the DBD, reconstituting the active transcription factor. This complex then binds to the upstream activating sequence (UAS) of a reporter gene, driving its expression (e.g., HIS3, ADE2, lacZ), which allows for selection and identification of positive interactions.

Protein-Small Molecule Interaction Screening (Chemical Y3H)

To identify protein targets of a specific small molecule, the system is adapted:

Hybrid Protein 1 (Hook): A protein with a known high affinity for a specific ligand (e.g., methotrexate) is fused to the DBD.
Hybrid Molecule (Bait): A synthetic, cell-permeable hybrid molecule is created, consisting of the ligand (methotrexate) chemically linked to your small molecule of interest.
Hybrid Protein 2 (Prey): A cDNA library of potential target proteins is fused to the AD.

The hybrid molecule acts as a bridge. The ligand portion binds to the DBD-fusion protein, and if the small molecule portion binds to a prey protein, the DBD and AD are brought together, activating the reporter gene.

Fig. 1 Schematic representation of Y3H assay. (OA Literature). Fig. 1 The idea of yeast three-hybrid (Y3H) system.¹

Creative Biolabs' Advanced Y3H Technology Platforms

Creative Biolabs is committed to staying at the vanguard of interaction screening technology. We offer a suite of advanced Y3H platforms tailored to your specific research objectives.

Platform	Principle	Key Applications
Classical Y3H	Detects ternary complexes where a third molecule (RNA or small molecule) bridges two proteins.	Identification of RNA-binding proteins (RBPs). Characterization of lncRNA-protein networks. Target identification for small molecules.
Reverse Y3H (R-Y3H)	Screens for molecules that disrupt a pre-existing ternary complex. Uses a counter-selectable marker (e.g., URA3).	High-throughput screening for inhibitors of essential RNA-protein interactions. Drug discovery for novel antibiotics or antiviral agents. Identification of compounds that modulate protein complex formation.
Chemical Y3H (YChemH)	A specialized platform optimized for identifying the direct protein targets of bioactive small molecules.	Target deconvolution for hits from phenotypic screens. Elucidating the mechanism of action (MoA) of drugs. Off-target profiling to predict potential side effects.
Y3H-Seq	Couples the Y3H screening process with Next-Generation Sequencing (NGS) for deep, quantitative analysis of interactors.	Genome-wide or proteome-wide interaction mapping. Quantitative assessment of interaction strengths. High-throughput discovery with reduced false positives.

Y3H based Protein Interaction Identification Service Workflow

Our service is a comprehensive, end-to-end solution, meticulously designed to deliver reliable and publication-ready data. Our expert team will guide you through every step of the process.

Project Consultation and Design: In-depth discussion with our Ph.D.-level scientists to understand your goals, select the optimal Y3H strategy, and design the bait/hook constructs.
Bait Construction and Validation: Cloning of your RNA bait, small-molecule bait synthesis, or protein hook construction. We perform rigorous quality control and bait validation, including tests for auto-activation and toxicity in yeast.
High-Quality Library Screening: Screening of your bait against our high-complexity, pre-made cDNA libraries (from human, mouse, etc.) or a custom-built library. We utilize high-stringency selection media to minimize false positives from the outset.
Hit Confirmation and Validation: Positive colonies are isolated and subjected to a series of validation steps, including re-streaking, 1-on-1 interaction re-testing, and reporter gene assays (e.g., β-galactosidase assay) to confirm true interactions.
Interactor Identification: The plasmids from validated positive clones are isolated, and the "prey" cDNA inserts are identified by high-fidelity DNA sequencing.
Bioinformatics Analysis and Comprehensive Reporting: We provide a detailed final report.

Features of the Y3H System

Choosing Creative Biolabs' Y3H service provides numerous advantages over other interaction discovery methods:

Versatile In Vivo System: Detects interactions within a cellular context, which is crucial for protein folding and post-translational modifications.
Unique Capability: The premier method for identifying RNA-protein and small molecule-protein interactions on a large scale.
High Sensitivity: Capable of detecting both transient and weak interactions that may be missed byin vitro methods like pull-down assays.
Scalability: Ideal for high-throughput screening of entire cDNA libraries to uncover novel interactors.
Direct Interaction Data: Provides direct evidence of a ternary complex, unlike co-immunoprecipitation which can identify indirect partners.
Cost-Effective Discovery: A powerful and economical tool for initial discovery phases before proceeding to more resource-intensive validation methods.

Applications of Y3H based Interaction Screening

Our Y3H services can be applied to a wide range of research areas to address fundamental biological questions:

Drug Discovery and Development:

Identify the molecular targets of novel drugs or natural products.
Screen for small molecule inhibitors that disrupt disease-relevant protein-protein or RNA-protein interactions.
Uncover off-target effects to improve drug safety profiles.

Functional Genomics:

Systematically map RNA-protein interaction networks (the "RBPome").
Elucidate the function of non-coding RNAs (e.g., lncRNAs, miRNAs) by identifying their protein partners.
Discover components of multi-protein signaling complexes.

Cellular and Molecular Biology:

Validate computationally predicted interactions.
Study how post-translational modifications or bridging proteins modulate interaction networks.
Investigate the mechanism of viral RNA replication and packaging through interactions with host proteins.

Why Choose Creative Biolabs?

Unmatched Experience: Over 20 years of dedicated service in the field of protein interaction analysis.
Cutting-Edge Technology: Continuous investment in the latest Y3H platforms and screening strategies.
Scientific Rigor: Robust protocols, stringent quality control, and comprehensive validation to ensure the highest data quality.
Customized Solutions: We don't offer a one-size-fits-all approach. We work with you to design a project that perfectly matches your research needs and budget.
Transparent Communication: A dedicated project manager provides regular updates and is always available to answer your questions.

Explore Our Full Suite of Interaction Analysis Services

Creative Biolabs offers a comprehensive portfolio of services to explore molecular interactions from every angle. Complement your Y3H study with our other world-class offerings:

Take the next step in unraveling the complex molecular networks that drive your research. Contact us today to discuss your project with one of our Y3H specialists and receive a no-obligation quote.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: What is the fundamental difference between the Yeast Two-Hybrid (Y2H) and the Yeast Three-Hybrid (Y3H) system?

A: The primary difference lies in the number of components being studied. The Yeast Two-Hybrid (Y2H) system is designed to detect a direct, binary interaction between two proteins (a "bait" and a "prey"). In contrast, the Yeast Three-Hybrid (Y3H) system is engineered to identify interactions within a ternary complex. It can identify a third molecule (often an RNA or a small molecule) that acts as a bridge between two proteins, or it can identify a protein that binds to a specific RNA or small molecule "bait". Y3H is the system of choice when your hypothesis involves a mediating molecule.

Q: My RNA molecule is highly structured. Can it still be used as a bait in a Y3H screen?

A: Yes, this is a key strength of the Y3H system. Because the screening occurs in vivo within the yeast cell, your RNA bait molecule is transcribed and can fold into its native, functional conformation. This cellular environment is far more representative of physiological conditions than in vitro assays, making it ideal for studying proteins that recognize specific secondary or tertiary RNA structures. Our team can also provide expert advice on bait design to optimize presentation and stability.

Q: Can any small molecule be used in a Chemical Y3H (YChemH) screen?

A: For a successful YChemH screen, the small molecule of interest must be chemically linked to a known "handle" or "ligand" (like methotrexate) to create a bifunctional bait. This requires that the small molecule has a suitable functional group for chemical conjugation that does not abolish its protein-binding activity. Furthermore, the resulting hybrid molecule must be cell-permeable to enter the yeast cell and nucleus. Our chemistry experts can assess the feasibility of your molecule and advise on the best synthetic strategy.

Q: What materials do I need to provide to start a Y3H project?

This depends on the project's nature.

For an RNA-protein screen: Typically, you would need to provide the sequence information for your RNA bait. We handle all cloning and synthesis.
For a small molecule-protein screen: You would need to provide the structure of the small molecule and, if available, a sample of the compound. We will then design the synthesis strategy for the hybrid bait.
For screening a custom library: You would provide the source material (e.g., cell pellets or frozen tissue) from which the library will be constructed.

Our project managers will provide a detailed list of requirements during the initial project consultation.

Reference

Czarnecka, Kamila, et al. "New cyclopentaquinoline and 3, 5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease." Journal of enzyme inhibition and medicinal chemistry 38.1 (2023): 2158822. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.1080/14756366.2022.2158822

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.